Core Laboratories Inc. (CLB)

Natixis Advisors L.P. Cuts Holdings in Core Laboratories Inc. (NYSE:CLB)

Natixis Advisors L.P. decreased its position in Core Laboratories Inc. (NYSE:CLB – Free Report) by 32.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,928 shares of the oil and gas company’s stock after selling 6,265 shares during the period. Natixis Advisors L.P.’s holdings in Core Laboratories were worth $228,000 at the end of the most recent quarter. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in Core Laboratories in the third quarter valued at $31,000. GAMMA Investing LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $48,000. PNC Financial Services Group Inc. increased its stake in shares of Core Laboratories by 72.7% during the third quarter. PNC Financial Services Group Inc. now owns 6,017 shares of the oil and gas company’s stock worth $144,000 after purchasing an additional 2,533 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Core Laboratories by 31.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,787 shares of the oil and gas company’s stock worth $259,000 after purchasing an additional 2,566 shares in the last quarter. Finally, Ballentine Partners LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $288,000. Hedge funds and other institutional investors own 97.81% of the company’s stock. Core Laboratories Stock Performance CLB opened at $18.04 on Monday. The firm has a market capitalization of $846.08 million, a PE ratio of 20.50, a PEG ratio of 1.02 and a beta of 2.40. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $27.94. The firm’s 50-day moving average price is $16.89 and its 200 day moving average price is $16.88. The company has a current ratio of 2.68, a quick ratio of 1.85 and a debt-to-equity ratio of 0.68. Core Laboratories (NYSE:CLB – Get Free Report) last posted its earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.02. The company had revenue of $129.64 million for the quarter, compared to analyst estimates of $124.47 million. Core Laboratories had a net margin of 8.18% and a return on equity of 15.71%. As a group, sell-side analysts expect that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year. Core Laboratories Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Monday, May 6th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $0.04 annualized dividend and a yield of 0.22%. Core Laboratories’s payout ratio is 4.55%. Wall Street Analysts Forecast Growth A number of analysts have recently commented on CLB shares. Stifel Nicolaus boosted their target price on shares of Core Laboratories from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Bank of America lowered their price target on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a research report on Monday, April 15th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $18.75. Check Out Our Latest Report on Core Laboratories About Core Laboratories (Free Report) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.